Want to join the conversation?
On June 4, $VRTX collaborated with Parion Sciences to develop investigational epithelial sodium channel inhibitors, including VX-371 and P-1055 for potential treatment of cystic fibrosis and other pulmonary diseases. $VRTX is responsible for all costs related to development and commercialization of the compounds.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!